The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury
Abstract The enzyme arginase 1 (A1) hydrolyzes the amino acid arginine to form L-ornithine and urea. Ornithine is further converted to polyamines by the ornithine decarboxylase (ODC) enzyme. We previously reported that deletion of myeloid A1 in mice exacerbates retinal damage after ischemia/reperfus...
Main Authors: | Esraa Shosha, Rami A. Shahror, Carol A. Morris, Zhimin Xu, Rudolf Lucas, Meghan E. McGee-Lawrence, Nancy J. Rusch, Ruth B. Caldwell, Abdelrahman Y. Fouda |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-09-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-06147-7 |
Similar Items
-
Retinal Neuroprotection From Optic Nerve Trauma by Deletion of Arginase 2
by: Zhimin Xu, et al.
Published: (2018-12-01) -
Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
by: Rami A. Shahror, et al.
Published: (2024-03-01) -
Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction
by: Esraa Shosha, et al.
Published: (2021-11-01) -
Metabolic Characterization of Hyoscyamus niger Ornithine Decarboxylase
by: Tengfei Zhao, et al.
Published: (2019-02-01) -
A safety catch for ornithine decarboxylase degradation
by: Christof Taxis
Published: (2015-05-01)